SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASE. Conclusion of a 41 Month Controlled Trial

JaneD Siegel, Norma Threlkeld, GeorgeH Mccracken, BonnieM Depasse, CharlesR Rosenfeld

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

The efficacy of a single dose of aqueous penicillin G in preventing neonatal group-B streptococcal infections was demonstrated in a randomised study conducted over 41 months. 16 082 infants received a single dose of penicillin within one hour of delivery, and 15 976 infants who received tetracycline ophthalmic ointment served as the control group. Group-B streptococcal systemic infections were significantly less common in the penicillin-treated infants (0·6 vs 1·7 cases per 1000 live births, p = 0·004). The incidence of infection caused by penicillin-resistant pathogens was insignificantly increased in the penicillin group (2·2 vs 1·6 cases per thousand live births, p = 0·32). This difference was accounted for almost completely by the events of the first 12 months of the study period when, for unexplained reasons, there was a considerable increase in the number of penicillin-resistant infections in the penicillin group (3·6 vs 1·4 cases per 1000 live births, p = 0·09). The mortality associated with penicillin-susceptible pathogens was higher in the control group (0·1 vs 0·4 per 1000 live births, p=0·18). However, the mortality associated with penicillin-resistant pathogens was increased in the penicillin group (0·4 vs 1·0 per 1000 live births, p = 0·06). The combined mortality rates for all pathogens were not significantly different (1·1 vs 0·7 per 1000 live births, p=0·27, for the penicillin and control groups, respectively) and were nearly equivalent when the excess number of deaths associted with penicillin-resistant infections in the penicillin group during the first study year was excluded from analysis. The incidence of gonococcal ophtalmia and chlamydial conjunctivitis was unaffected by the use of intramuscular penicillin at birth.

Original languageEnglish (US)
Pages (from-to)1426-1430
Number of pages5
JournalThe Lancet
Volume319
Issue number8287
DOIs
StatePublished - Jun 26 1982

Fingerprint

Penicillins
Live Birth
Streptococcal Infections
Control Groups
Mortality
Infection
Conjunctivitis
Penicillin G
Incidence
Ointments
Tetracycline
Parturition

ASJC Scopus subject areas

  • Medicine(all)

Cite this

SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASE. Conclusion of a 41 Month Controlled Trial. / Siegel, JaneD; Threlkeld, Norma; Mccracken, GeorgeH; Depasse, BonnieM; Rosenfeld, CharlesR.

In: The Lancet, Vol. 319, No. 8287, 26.06.1982, p. 1426-1430.

Research output: Contribution to journalArticle

@article{798c6ab5d42d42ca90b1fcdc3889bc5e,
title = "SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASE. Conclusion of a 41 Month Controlled Trial",
abstract = "The efficacy of a single dose of aqueous penicillin G in preventing neonatal group-B streptococcal infections was demonstrated in a randomised study conducted over 41 months. 16 082 infants received a single dose of penicillin within one hour of delivery, and 15 976 infants who received tetracycline ophthalmic ointment served as the control group. Group-B streptococcal systemic infections were significantly less common in the penicillin-treated infants (0·6 vs 1·7 cases per 1000 live births, p = 0·004). The incidence of infection caused by penicillin-resistant pathogens was insignificantly increased in the penicillin group (2·2 vs 1·6 cases per thousand live births, p = 0·32). This difference was accounted for almost completely by the events of the first 12 months of the study period when, for unexplained reasons, there was a considerable increase in the number of penicillin-resistant infections in the penicillin group (3·6 vs 1·4 cases per 1000 live births, p = 0·09). The mortality associated with penicillin-susceptible pathogens was higher in the control group (0·1 vs 0·4 per 1000 live births, p=0·18). However, the mortality associated with penicillin-resistant pathogens was increased in the penicillin group (0·4 vs 1·0 per 1000 live births, p = 0·06). The combined mortality rates for all pathogens were not significantly different (1·1 vs 0·7 per 1000 live births, p=0·27, for the penicillin and control groups, respectively) and were nearly equivalent when the excess number of deaths associted with penicillin-resistant infections in the penicillin group during the first study year was excluded from analysis. The incidence of gonococcal ophtalmia and chlamydial conjunctivitis was unaffected by the use of intramuscular penicillin at birth.",
author = "JaneD Siegel and Norma Threlkeld and GeorgeH Mccracken and BonnieM Depasse and CharlesR Rosenfeld",
year = "1982",
month = "6",
day = "26",
doi = "10.1016/S0140-6736(82)92449-7",
language = "English (US)",
volume = "319",
pages = "1426--1430",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8287",

}

TY - JOUR

T1 - SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASE. Conclusion of a 41 Month Controlled Trial

AU - Siegel, JaneD

AU - Threlkeld, Norma

AU - Mccracken, GeorgeH

AU - Depasse, BonnieM

AU - Rosenfeld, CharlesR

PY - 1982/6/26

Y1 - 1982/6/26

N2 - The efficacy of a single dose of aqueous penicillin G in preventing neonatal group-B streptococcal infections was demonstrated in a randomised study conducted over 41 months. 16 082 infants received a single dose of penicillin within one hour of delivery, and 15 976 infants who received tetracycline ophthalmic ointment served as the control group. Group-B streptococcal systemic infections were significantly less common in the penicillin-treated infants (0·6 vs 1·7 cases per 1000 live births, p = 0·004). The incidence of infection caused by penicillin-resistant pathogens was insignificantly increased in the penicillin group (2·2 vs 1·6 cases per thousand live births, p = 0·32). This difference was accounted for almost completely by the events of the first 12 months of the study period when, for unexplained reasons, there was a considerable increase in the number of penicillin-resistant infections in the penicillin group (3·6 vs 1·4 cases per 1000 live births, p = 0·09). The mortality associated with penicillin-susceptible pathogens was higher in the control group (0·1 vs 0·4 per 1000 live births, p=0·18). However, the mortality associated with penicillin-resistant pathogens was increased in the penicillin group (0·4 vs 1·0 per 1000 live births, p = 0·06). The combined mortality rates for all pathogens were not significantly different (1·1 vs 0·7 per 1000 live births, p=0·27, for the penicillin and control groups, respectively) and were nearly equivalent when the excess number of deaths associted with penicillin-resistant infections in the penicillin group during the first study year was excluded from analysis. The incidence of gonococcal ophtalmia and chlamydial conjunctivitis was unaffected by the use of intramuscular penicillin at birth.

AB - The efficacy of a single dose of aqueous penicillin G in preventing neonatal group-B streptococcal infections was demonstrated in a randomised study conducted over 41 months. 16 082 infants received a single dose of penicillin within one hour of delivery, and 15 976 infants who received tetracycline ophthalmic ointment served as the control group. Group-B streptococcal systemic infections were significantly less common in the penicillin-treated infants (0·6 vs 1·7 cases per 1000 live births, p = 0·004). The incidence of infection caused by penicillin-resistant pathogens was insignificantly increased in the penicillin group (2·2 vs 1·6 cases per thousand live births, p = 0·32). This difference was accounted for almost completely by the events of the first 12 months of the study period when, for unexplained reasons, there was a considerable increase in the number of penicillin-resistant infections in the penicillin group (3·6 vs 1·4 cases per 1000 live births, p = 0·09). The mortality associated with penicillin-susceptible pathogens was higher in the control group (0·1 vs 0·4 per 1000 live births, p=0·18). However, the mortality associated with penicillin-resistant pathogens was increased in the penicillin group (0·4 vs 1·0 per 1000 live births, p = 0·06). The combined mortality rates for all pathogens were not significantly different (1·1 vs 0·7 per 1000 live births, p=0·27, for the penicillin and control groups, respectively) and were nearly equivalent when the excess number of deaths associted with penicillin-resistant infections in the penicillin group during the first study year was excluded from analysis. The incidence of gonococcal ophtalmia and chlamydial conjunctivitis was unaffected by the use of intramuscular penicillin at birth.

UR - http://www.scopus.com/inward/record.url?scp=0020045024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020045024&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(82)92449-7

DO - 10.1016/S0140-6736(82)92449-7

M3 - Article

C2 - 6123719

AN - SCOPUS:0020045024

VL - 319

SP - 1426

EP - 1430

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8287

ER -